Zynext Ventures
Venture arm of Zydus Lifesciences investing in seed, early and growth-stage healthcare companies across drug delivery, medical imaging and pharmaceutical technology.
Zynext Ventures is the venture investment platform of Zydus Lifesciences, a global pharmaceutical group. It invests at seed and early stage in disruptive healthcare technologies, and also backs growth-stage healthcare companies. Beyond capital, the firm provides strategic guidance and industry expertise drawn from its parent company's pharmaceutical operations.
Its stated areas of interest include intracellular drug delivery, medical imaging technologies, medical intervention technologies, healthcare technology innovation and pharmaceutical technology. The relevant market verticals span healthcare, pharmaceuticals, biotechnology, medical devices, drug delivery and medical imaging. The firm describes its mandate as identifying and nurturing innovators developing novel, life-changing solutions, with a focus on unmet needs.
As a corporate venture platform, Zynext Ventures combines financial support with the operational and scientific reach of Zydus Lifesciences, giving portfolio companies access to industry expertise alongside funding. The firm is based in Pennington, New Jersey, with global reach through its parent company. Healthcare startups developing novel solutions are invited to contact the team directly.